- Opportunities for incorporating AI into clinical research: where should the industry be focusing?
- Why has pharma been relatively slow to utilize AI in clinical research?
- Understanding limitations of GenAI: what do you need to be wary of?
- Real case studies on AI in the clinical trial industry: where has there been progress and success?
- What does the future hold for AI in clinical trials?
MODERATOR:
Judyth Zahora, Senior Director, Clinical QA and Process Improvement, Zentalis Pharmaceuticals
PANELLISTS:
Rosanne Petros, Associate Director, Clinical Research, Merck Research Laboratories
Bryan Clayton, Clinical Systems Consultant, Alnylam Pharmaceuticals
Paresh Patel, Head of Global Clinical Intelligence, Otsuka